Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Langer

Showing results (481-490 of 596) with videos related to

Pageof 60
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 18, 2020
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLCMark M Awad, Shirish M Gadgeel, Hossein Borghaei, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLCCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2017
Current and Emergent Therapy Options for Advanced Squamous Cell Lung CancerMark A Socinski, Coleman Obasaju, David Gandara, et al.
Radiation Research|March 28, 2008
Ultrasound-detected thyroid nodule prevalence and radiation dose from falloutC E Land, Z Zhumadilov, B I Gusev, et al.
Transplantation and Cellular Therapy|August 18, 2024
Surrogates of Endothelial Injury Predict Survival After Post-transplant CyclophosphamideAnmol Baranwal, Kimberly J Langer, Mohamed A Kharfan-Dabaja, et al.
American Journal of Clinical Oncology|November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant ChemoimmunotherapyCole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
Pain|September 5, 2006
Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic painErin D Milligan, Evan M Sloane, Stephen J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Clinicopathologic Features of Advanced Squamous NSCLCMark A Socinski, Coleman Obasaju, David Gandara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 24, 2018
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung CancerHossein Borghaei, Corey J Langer, Shirish Gadgeel, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
Pageof 60

Showing results (481-490 of 596) with videos related to

Sort By:
Pageof 60
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 18, 2020
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLCMark M Awad, Shirish M Gadgeel, Hossein Borghaei, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2023
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLCCole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2017
Current and Emergent Therapy Options for Advanced Squamous Cell Lung CancerMark A Socinski, Coleman Obasaju, David Gandara, et al.
Radiation Research|March 28, 2008
Ultrasound-detected thyroid nodule prevalence and radiation dose from falloutC E Land, Z Zhumadilov, B I Gusev, et al.
Transplantation and Cellular Therapy|August 18, 2024
Surrogates of Endothelial Injury Predict Survival After Post-transplant CyclophosphamideAnmol Baranwal, Kimberly J Langer, Mohamed A Kharfan-Dabaja, et al.
American Journal of Clinical Oncology|November 6, 2025
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant ChemoimmunotherapyCole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, et al.
Pain|September 5, 2006
Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic painErin D Milligan, Evan M Sloane, Stephen J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Clinicopathologic Features of Advanced Squamous NSCLCMark A Socinski, Coleman Obasaju, David Gandara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 24, 2018
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung CancerHossein Borghaei, Corey J Langer, Shirish Gadgeel, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
Pageof 60